Who are Verisian's investors?

Verisian's investors include Cambridge Angels group, Recode Ventures, Seedcamp, SuperSeed, 6 Dimensions Capital, ManchesterStory Group, LLC.

Verisian

Founded 2023 · 24 employees on LinkedIn · 6 known investors

Find your way into Verisian

Paths you didn't know you had: your email and LinkedIn already hold routes to the Verisian team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.

Biotech Digital Health Healthtech SaaS

Founders & leadership

Henning KuichFounder

Tomas SabatFounder

Board

Sunil GuptaStrategic Advisor

Investors · 6

Cambridge Angels grouplisted by Cambridge Angels groupCambridge · $195K – $1.9M

How we know: Cambridge Angels group's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Recode Ventureslisted by Recode VenturesSan Franciscovia Armen Vidian · inferred

How we know: Recode Ventures's portfolio page · Not right? Tell us

Seedcamplisted by SeedcampLondon · $378K – $1.1M

How we know: Seedcamp's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

SuperSeedlisted by SuperSeedLondon · $127K – $635K

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

6 Dimensions CapitalreportedGrand Cayman

How we know: a partner's Signal profile · Not right? Tell us

ManchesterStory Group, LLCreportedWest Des Moines

How we know: a partner's Signal profile · Not right? Tell us

Related companies · 3

InstemInstem provides SaaS platforms and services for research and development in the life sciences industry, serving pharmaceutical companies, CROs, CDMOs, academic research institutions, biotechnology firms, industrial organizations, and agrichemical companies.

SaamaSaama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.

NarrativaNarrativa provides generative AI automation for medical writing, focused on drafting patient safety narratives and clinical trial regulatory documentation for pharmaceutical companies. Its platform automates data analysis and narrative authoring to speed up drug trial documentation and regulatory approvals.

Companies working in the same space as Verisian.

Frequently asked questions

What does Verisian do?: Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.
Who are Verisian's investors?: Verisian's investors include Cambridge Angels group, Recode Ventures, Seedcamp, SuperSeed, 6 Dimensions Capital, ManchesterStory Group, LLC.